Stivarga
NDC 50419-171, regorafenib, tablet, film coated, from Bayer HealthCare Pharmaceuticals Inc..
- Product NDC
- 50419-171
- Status
- Listed
- Labeler
- Bayer HealthCare Pharmaceuticals Inc.
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA203085
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/50419-171 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- REGORAFENIB40 mg/1
Pharmacologic classes
Breast Cancer Resistance Protein Inhibitors [MoA]; Cytochrome P450 2C9 Inhibitors [MoA]; Kinase Inhibitor [EPC]; Kinase Inhibitors [MoA]; UGT1A1 Inhibitors [MoA]; UGT1A9 Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 50419-171-00 | 50419017100 | 210 BOTTLE in 1 BOX (50419-171-00) / 28 TABLET, FILM COATED in 1 BOTTLE |
| 50419-171-03 | 50419017103 | 3 BOTTLE, PLASTIC in 1 BOX (50419-171-03) / 28 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (50419-171-01) |
| 50419-171-04 | 50419017104 | 1 BOTTLE, PLASTIC in 1 CARTON (50419-171-04) / 28 TABLET, FILM COATED in 1 BOTTLE, PLASTIC |
| 50419-171-06 | 50419017106 | 4 BOTTLE, PLASTIC in 1 CARTON (50419-171-06) / 21 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (50419-171-05) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/824f19c9-0546-4a8a-8d8f-c4055c04f7c7
Use it
Look up 50419-171 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/50419-171 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 50419-171. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.